Increased duration of time without transfusion reliance with imetelstat vs placebo in the phase 3 IMerge trial
- DOI
- 10.1016/j.bneo.2026.100216
- Published
- 2026-05
- Container
- Blood Neoplasia
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.bneo.2026.100216,
title = {Increased duration of time without transfusion reliance with imetelstat vs placebo in the phase 3 IMerge trial},
author = {Mikkael A. Sekeres and Valeria Santini and Amer M. Zeidan and Uwe Platzbecker and Rami S. Komrokji and María Díez-Campelo and Pierre Fenaux and Michael R. Savona and Yazan F. Madanat and David Valcárcel and Antoine Regnault and Flora Mazerolle and Libo Sun and Ying Wan and Tymara Berry and Faye Feller and Shyamala Navada and Esther Natalie Oliva},
year = {2026},
journal = {Blood Neoplasia},
doi = {10.1016/j.bneo.2026.100216},
url = {https://doi.org/10.1016/j.bneo.2026.100216}
}RIS
TY - JOUR TI - Increased duration of time without transfusion reliance with imetelstat vs placebo in the phase 3 IMerge trial AU - Mikkael A. Sekeres AU - Valeria Santini AU - Amer M. Zeidan AU - Uwe Platzbecker AU - Rami S. Komrokji AU - María Díez-Campelo AU - Pierre Fenaux AU - Michael R. Savona AU - Yazan F. Madanat AU - David Valcárcel AU - Antoine Regnault AU - Flora Mazerolle AU - Libo Sun AU - Ying Wan AU - Tymara Berry AU - Faye Feller AU - Shyamala Navada AU - Esther Natalie Oliva PY - 2026 JO - Blood Neoplasia DO - 10.1016/j.bneo.2026.100216 UR - https://doi.org/10.1016/j.bneo.2026.100216 ER -
APA
Sekeres, M. A., Santini, V., Zeidan, A. M., Platzbecker, U., Komrokji, R. S., Díez-Campelo, M., Fenaux, P., Savona, M. R., Madanat, Y. F., Valcárcel, D., Regnault, A., Mazerolle, F., Sun, L., Wan, Y., Berry, T., Feller, F., Navada, S., & Oliva, E. N. (2026). Increased duration of time without transfusion reliance with imetelstat vs placebo in the phase 3 IMerge trial. Blood Neoplasia. https://doi.org/10.1016/j.bneo.2026.100216
Source records
- crossref · retrieved 2026-09-26T05:01:59.599Z